EUR · 1 valued
€2.62 million
Supplier · public contract awards
HIKMA PHARMA GMBH, ribosepharm division public contracts.
HIKMA PHARMA GMBH, ribosepharm division has won 60 public contracts between 2020 and 2021 from 9 public buyers in Germany. Its most frequent buyer is GWQ ServicePlus AG (28 awards). Outside TED, published values total €2.62 million across 1 award.
60Contracts won
9Public buyers
1Country
Feb 2021Latest award
Latest contracts won
Nicht-exklusive Arzneimittel-Rabattvereinbarungen nach § 130a Abs. 8 SGB V mit jederzeitiger Abschlussmöglichkeit für die unter Punkt II.1.4) aufgefüh
Awarded by AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · Germany
17 Feb 2021Awarded
Nicht-exklusive Arzneimittel-Rabattvereinbarungen nach § 130a Abs. 8 SGB V mit jederzeitiger Abschlussmöglichkeit für die unter Punkt II.1.4) aufgefüh
Awarded by AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · Germany
17 Dec 2020Awarded
Nicht-exklusive Arzneimittel-Rabattvereinbarungen nach § 130a Abs. 8 SGB V mit jederzeitiger Abschlussmöglichkeit für die unter Punkt II.1.4) aufgefüh
Awarded by AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · Germany
20 Aug 2020Awarded
Contracts won by year
Contracts won by year
from the published recordsPublished value, by currency (feeds other than TED)
From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted. TED values are often framework ceilings, so TED awards show a median contract size, never a total.
Bid with askTender
Bidding against HIKMA PHARMA GMBH, ribosepharm division?
askTender reads every open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.
Start bidding See open tenders